Delivery Order SPE2DR25D2101-SPE2DR26F45UV
Award Date 11/20/25
Potential Completion Date 12/12/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of LONSURF (15 mg-6.14 mg tablets) in a quantity of 40 units, with a ceiling value of $10,248.32 and firm fixed pricing. The contract is non-set-aside and represents a competitively awarded delivery order, with an ultimate completion date of November 24, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $10,173.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of LONSURF (trifluridine/tipiracil) 20 mg-8.19 mg tablets in quantities of 60 units. This delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), is scheduled for completion by September 30, 2025, with performance at the vendor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,539.15 to AmerisourceBergen Drug Corp for LONSURF 15 mg-6.14 mg tablets (20-count units) on September 25, 2025, with an ultimate completion date of October 17, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this delivery order, which represents a single transaction under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $5,078.30 to AmerisourceBergen Drug Corp for the supply of LONSURF (15 mg-6.14 mg tablets, quantity 20) with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. LONSURF is an FDA-approved combination chemotherapy medication used in oncology treatment,...
- The Defense Logistics Agency awarded a $30,519.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LONSURF (20 mg-8.19 mg tablets, 60-count packages) on September 22, 2025, with an ultimate completion date of October 14, 2025. This delivery order was awarded competitively without set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of LONSURF (20 mg-8.19 mg tablets, 60-count packages) with a ceiling value of $10,173.33. This competitively awarded, non-set-aside contract is scheduled for completion by September 30, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of LONSURF (15 mg-6.14 mg tablets) in a quantity of 40 units, with a ceiling value of $5,124.17 and firm fixed pricing. This delivery order, which is not set-aside, is scheduled for completion by August 28, 2025, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $6.76K to AmerisourceBergen Drug Corp for the supply of LONSURF 20 mg–8.19 mg tablets (40-count packages). This non-competitive, firm fixed-price delivery order was issued on June 16, 2025, with an ultimate completion date of July 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. LONSURF is a combination chemotherapy medication used in cancer treatment, reflecting the breadth of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LONSURF (20 mg-8.19 mg tablets, 20-count) on October 22, 2025, with a ceiling value of $6,813.86 and an ultimate completion date of November 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the company's extensive pharmaceutical supply relationship with the federal government. AmerisourceBergen Drug Corp, headquartered...
- The Defense Logistics Agency awarded a delivery order valued at $21.6K to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Lonsurf (15 mg-6.14 mg tablets, 40-count packaging) with a completion date of December 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...